Within the crowded ecosystem of the human gut, trillions of bacteria coexist with an immune system that has learned, most of the time, to leave them alone. St. Jude Children's Research Hospital researchers have now traced part of that quiet truce to a gene-regulatory pathway called COMPASS, which allows a specialized class of immune cells to keep watch without overreacting. Their findings, reported in Science Advances, suggest that a general-purpose biological tool can serve a surprisingly precise role in preserving tolerance. The work offers a new way to think about why some people's bodies t
A Gene Pathway Known as COMPASS Lets Regulatory T Cells Keep Gut Inflammation in Check
A broadly used gene pathway can have a specialized role in immune balance
Mark
Start with the basic puzzle. Why doesn't the immune system attack gut bacteria?
Mimi
Regulatory T cells hold the other immune cells back from reacting to them. This study identifies one gene, Wdr82, part of the COMPASS pathway, that those cells need to do it.
Mark
What happened when the gene was removed?
Mimi
In mice, deleting Wdr82 in T cells caused severe intestinal inflammation and autoimmunity, with milder effects in the heart and lungs. It eventually became lethal.
Luke
Worth stating plainly: that's mice. The source reports nothing from human patients.
Mark
Fair. What makes the result convincing within the mice?
Mimi
Two rescues. Adding regulatory T cells with working Wdr82 reversed the disease and prevented death, and antibiotics that depleted most gut bacteria also stopped the inflammation.
Luke
Those rescues support the bacteria-trigger explanation in these models. But the source doesn't say which bacteria are involved, or how COMPASS acts inside the cell.
Mark
And the bigger idea?
Mimi
Wdr82 is present in many T-cell types, yet only regulatory T cells lost their function. Effector T cells kept theirs.
Luke
The link to inflammatory bowel disease and food allergies is a stated possibility, not a demonstrated one. Feng speaks of beginning to look back at human variants; that work hasn't been reported.
O Pulso
- When a gene called Wdr82 was removed from mouse T cells, the animals' guts erupted in inflammation that spread to the heart and lungs and ultimately proved fatal.
- The immune system's peacekeepers, the regulatory T cells, lost their ability to tell harmless gut bacteria from threats, turning routine residents into triggers for attack.
- Researchers restored function by supplying regulatory T cells with an intact Wdr82 gene, and antibiotics that cleared most gut bacteria also halted the damage.
- The discovery upends the assumption that broadly used genetic regulators behave identically across immune cell types, opening a search through overlooked disease variants.
- The team's next move is to revisit patient gene variants once dismissed as irrelevant, testing whether they quietly disable regulatory T cells in conditions like inflammatory bowel disease.
Within the crowded ecosystem of the human gut, trillions of bacteria coexist with an immune system that has learned, most of the time, to leave them alone. St. Jude Children's Research Hospital researchers have now traced part of that quiet truce to a gene-regulatory pathway called COMPASS, which allows a specialized class of immune cells to keep watch without overreacting. Their findings, reported in Science Advances, suggest that a general-purpose biological tool can serve a surprisingly precise role in preserving tolerance. The work offers a new way to think about why some people's bodies turn against themselves, and where the answers might still be hiding.
Trillions of bacteria live in the human gut, and most of the time the immune system chooses restraint. Researchers at St. Jude Children's Research Hospital set out to understand the genetic machinery behind that restraint, particularly the regulatory T cells whose job is to calm other immune cells when they overreact to those bacteria. A CRISPR screen pointed to Wdr82, a component of COMPASS, a widely known pathway that switches genes on.
When the team deleted Wdr82 from T cells in mice, the consequences were severe. Inflammation took hold in the intestine and, to a lesser degree, in the heart and lungs, and the disease eventually proved lethal. Restoring regulatory T cells with a working copy of the gene reversed the illness, and antibiotics that cleared most gut bacteria stopped it as well, confirming that the bacteria were the source of the alarm.
The most surprising result was the asymmetry. Wdr82 is present across T-cell types, yet only the regulatory cells lost their protective role, while inflammatory effector cells carried on unchanged. Yongqiang Feng, the study's corresponding author, said the field had assumed such general regulators work the same everywhere, and this work shows they can have specialized effects.
That insight may matter far beyond the lab. Scientists have often set aside broadly expressed genes in their analyses, which could explain why some autoimmune conditions, including inflammatory bowel disease and food allergies, still lack clear causes or cures. Feng's team now plans to revisit genetic variants in patients that once seemed irrelevant, asking whether they selectively disable regulatory T cells and how that might be treated.
Trillions of bacteria live in the human gut, and the immune system leaves them alone. Researchers at St. Jude Children's Research Hospital have now identified a piece of the machinery that helps keep that peace, and they report it in a paper published in Science Advances.
The immune system is built to separate self from non-self and to eliminate what it judges foreign, such as viruses and bacteria. The gut complicates that job because it hosts the intestinal microbiota, a community of beneficial bacteria. Regulatory T cells are the cells that stop other immune cells from reacting inappropriately to those bacteria. What genetic factors governed that role had been poorly understood.
To find them, the St. Jude team ran a CRISPR screen. It pointed to a gene called Wdr82, a key component of COMPASS, a well-known general pathway for activating genes. The screen indicated that Wdr82 is essential for regulatory T cells to maintain tolerance in the intestine.
The researchers then tested this in mice. When they deleted Wdr82 in T cells, severe inflammation and autoimmunity developed in the intestine and, to a lesser extent, in the heart and lungs. The disease eventually became lethal. Giving the animals functional regulatory T cells with intact Wdr82 reversed the disease and prevented death. So did antibiotics, which depleted most of the gut bacteria and stopped the inflammation and its consequences.
Yongqiang Feng, PhD, the corresponding author and a member of the St. Jude Department of Immunology, said that under normal conditions the COMPASS pathway lets regulatory T cells prevent inflammation and autoimmunity in the intestine. When the pathway is compromised, he said, the immune system stops recognizing the bacteria as harmless and treats them as inflammatory triggers. In his words, regulatory T cells with COMPASS defects cannot serve as a protective barrier between gut bacteria and the inflammatory responses of other immune cells.
The finding also challenges an assumption. Wdr82 is expressed across T-cell types, yet losing it did not affect them equally. Regulatory T cells lost their protective function, while inflammatory effector T cells kept their activity. A broadly used gene-regulatory pathway, in other words, can play a specialized role in immune balance. Feng said the field had assumed general gene expression regulators like Wdr82 work the same way in every type of T cell, and that the study introduces the idea that such factors can have asymmetric effects across T-cell subtypes.
The authors suggest this asymmetry may be hiding sources of unexplained autoimmunity. Scientists have often excluded broadly expressed genes from their analyses, assuming they behave alike in all cell types. Looking at how general pathways work in specific immune populations could reveal overlooked mechanisms, and a better understanding of inflammatory bowel disease, food allergies and other autoimmune conditions that still have no cure.
Feng pointed to genetic variants found in patients with autoimmune disease, which may have been dismissed because they seemed irrelevant to T cells as a whole. The next step he described is to revisit those variants and ask whether they selectively affect a particular T-cell subtype, then work out how they cause disease and open a path to new treatments.
Citações Notáveis
General regulatory factors can have asymmetric effects across T-cell subtypes, performing specialized roles in particular immunological processes.— Yongqiang Feng, PhD, corresponding author, St. Jude Department of Immunology
Quer a matéria completa?
Leia o original em News-Medical ↗
Science & Space